Literature DB >> 33488578

CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.

Blagoje Soskic1, Louisa E Jeffery2, Alan Kennedy1, David H Gardner3, Tie Zheng Hou1, Neil Halliday1, Cayman Williams1, Daniel Janman1, Behzad Rowshanravan1, Gideon M Hirschfield4, David M Sansom1.   

Abstract

CD80 and CD86 are expressed on antigen presenting cells (APCs) and their role in providing costimulation to T cells is well established. However, it has been shown that these molecules can also be expressed by T cells, but the significance of this observation remains unknown. We have investigated stimuli that control CD80 and CD86 expression on T cells and show that in APC-free conditions around 40% of activated, proliferating CD4+ T cells express either CD80, CD86 or both. Expression of CD80 and CD86 was strongly dependent upon provision of CD28 costimulation as ligands were not expressed following TCR stimulation alone. Furthermore, we observed that CD80+ T cells possessed the hallmarks of induced regulatory T cells (iTreg), expressing Foxp3 and high levels of CTLA-4 whilst proliferating less extensively. In contrast, CD86 was preferentially expressed on INF-γ producing cells, which proliferated more extensively and had characteristics of effector T cells. Finally, we demonstrated that CD80 expressed on T cells inhibits CTLA-4 function and facilitates the growth of iTreg. Together these data establish endogenous expression of CD80 and CD86 by activated T cells is not due to ligand capture by transendocytosis and highlight clear differences in their expression patterns and associated functions.
Copyright © 2021 Soskic, Jeffery, Kennedy, Gardner, Hou, Halliday, Williams, Janman, Rowshanravan, Hirschfield and Sansom.

Entities:  

Keywords:  CD28 costimulation; CD80 and CD86; CTLA-4; T cell activation; Treg

Year:  2021        PMID: 33488578      PMCID: PMC7820758          DOI: 10.3389/fimmu.2020.577655

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  50 in total

1.  Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.

Authors:  Keunwook Lee; Prathyusha Gudapati; Srdjan Dragovic; Charles Spencer; Sebastian Joyce; Nigel Killeen; Mark A Magnuson; Mark Boothby
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

2.  Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.

Authors:  Benjamin J Schmiedel; Divya Singh; Ariel Madrigal; Alan G Valdovino-Gonzalez; Brandie M White; Jose Zapardiel-Gonzalo; Brendan Ha; Gokmen Altay; Jason A Greenbaum; Graham McVicker; Grégory Seumois; Anjana Rao; Mitchell Kronenberg; Bjoern Peters; Pandurangan Vijayanand
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

Review 3.  Regulation of T cells by mTOR: the known knowns and the known unknowns.

Authors:  Kristen N Pollizzi; Jonathan D Powell
Journal:  Trends Immunol       Date:  2014-12-16       Impact factor: 16.687

4.  Integration of CD28 and CTLA-4 function results in differential responses of T cells to CD80 and CD86.

Authors:  Claire N Manzotti; Michael K P Liu; Fiona Burke; Laure Dussably; Yong Zheng; David M Sansom
Journal:  Eur J Immunol       Date:  2006-06       Impact factor: 5.532

5.  Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.

Authors:  Omar S Qureshi; Yong Zheng; Kyoko Nakamura; Kesley Attridge; Claire Manzotti; Emily M Schmidt; Jennifer Baker; Louisa E Jeffery; Satdip Kaur; Zoe Briggs; Tie Z Hou; Clare E Futter; Graham Anderson; Lucy S K Walker; David M Sansom
Journal:  Science       Date:  2011-04-07       Impact factor: 47.728

6.  The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions.

Authors:  T Wyss-Coray; D Mauri-Hellweg; K Baumann; F Bettens; R Grunow; W J Pichler
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

7.  A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.

Authors:  Tie Zheng Hou; Omar S Qureshi; Chun Jing Wang; Jennifer Baker; Stephen P Young; Lucy S K Walker; David M Sansom
Journal:  J Immunol       Date:  2015-01-28       Impact factor: 5.422

8.  T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells.

Authors:  I Hwang; J F Huang; H Kishimoto; A Brunmark; P A Peterson; M R Jackson; C D Surh; Z Cai; J Sprent
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

9.  A genome-wide association study identifies six novel risk loci for primary biliary cholangitis.

Authors:  Fang Qiu; Ruqi Tang; Xianbo Zuo; Xingjuan Shi; Yiran Wei; Xiaodong Zheng; Yaping Dai; Yuhua Gong; Lan Wang; Ping Xu; Xiang Zhu; Jian Wu; Chongxu Han; Yueqiu Gao; Kui Zhang; Yuzhang Jiang; Jianbo Zhou; Youlin Shao; Zhigang Hu; Ye Tian; Haiyan Zhang; Na Dai; Lei Liu; Xudong Wu; Weifeng Zhao; Xiaomin Zhang; Zhidong Zang; Jinshan Nie; Weihao Sun; Yi Zhao; Yuan Mao; Po Jiang; Hualiang Ji; Qing Dong; Junming Li; Zhenzhong Li; Xinli Bai; Li Li; Maosong Lin; Ming Dong; Jinxin Li; Ping Zhu; Chan Wang; Yanqiu Zhang; Peng Jiang; Yujue Wang; Rohil Jawed; Jing Xu; Yu Zhang; Qixia Wang; Yue Yang; Fan Yang; Min Lian; Xiang Jiang; Xiao Xiao; Yanmei Li; Jingyuan Fang; Dekai Qiu; Zhen Zhu; Hong Qiu; Jianqiong Zhang; Wenyan Tian; Sufang Chen; Ling Jiang; Bing Ji; Ping Li; Guochang Chen; Tianxue Wu; Yan Sun; Jianjiang Yu; Huijun Tang; Michun He; Min Xia; Hao Pei; Lihua Huang; Zhuye Qing; Jianfang Wu; Qinghai Huang; Junhai Han; Wei Xie; Zhongsheng Sun; Jian Guo; Gengsheng He; M Eric Gershwin; Zhexiong Lian; Xiang Liu; Michael F Seldin; Xiangdong Liu; Weichang Chen; Xiong Ma
Journal:  Nat Commun       Date:  2017-04-20       Impact factor: 14.919

10.  Functional expression of B7/BB1 on activated T lymphocytes.

Authors:  M Azuma; H Yssel; J H Phillips; H Spits; L L Lanier
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  2 in total

1.  Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity.

Authors:  Yan Mu; Xiao-He Ren; Di Han; Ying-Ying Guan; Pei-Ling Liu; Si-Xue Cheng; Hong Liu
Journal:  Pharmaceutics       Date:  2022-07-09       Impact factor: 6.525

2.  Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.

Authors:  Alan Kennedy; Erin Waters; Behzad Rowshanravan; Claudia Hinze; Cayman Williams; Daniel Janman; Thomas A Fox; Claire Booth; Anne M Pesenacker; Neil Halliday; Blagoje Soskic; Satdip Kaur; Omar S Qureshi; Emma C Morris; Shinji Ikemizu; Christopher Paluch; Jiandong Huo; Simon J Davis; Emmanuel Boucrot; Lucy S K Walker; David M Sansom
Journal:  Nat Immunol       Date:  2022-08-23       Impact factor: 31.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.